List of Tables
Table 1. Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Long-Acting Reversible Contraception(LARC) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Long-Acting Reversible Contraception(LARC) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Long-Acting Reversible Contraception(LARC), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Product Type & Application
Table 12. Global Key Manufacturers of Long-Acting Reversible Contraception(LARC), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Long-Acting Reversible Contraception(LARC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Reversible Contraception(LARC) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Long-Acting Reversible Contraception(LARC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2019-2024) & (K Units)
Table 18. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2019-2024)
Table 19. Global Long-Acting Reversible Contraception(LARC) Sales by Region (2025-2030) & (K Units)
Table 20. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2025-2030)
Table 21. Global Long-Acting Reversible Contraception(LARC) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2019-2024)
Table 23. Global Long-Acting Reversible Contraception(LARC) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2025-2030)
Table 25. North America Long-Acting Reversible Contraception(LARC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2024) & (K Units)
Table 27. North America Long-Acting Reversible Contraception(LARC) Sales by Country (2025-2030) & (K Units)
Table 28. North America Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Long-Acting Reversible Contraception(LARC) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Long-Acting Reversible Contraception(LARC) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Long-Acting Reversible Contraception(LARC) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Long-Acting Reversible Contraception(LARC) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Long-Acting Reversible Contraception(LARC) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Long-Acting Reversible Contraception(LARC) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Long-Acting Reversible Contraception(LARC) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) by Type (2019-2024)
Table 51. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) by Type (2025-2030)
Table 52. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2019-2024)
Table 53. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Type (2025-2030)
Table 54. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2019-2024)
Table 57. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Type (2025-2030)
Table 58. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) by Application (2019-2024)
Table 61. Global Long-Acting Reversible Contraception(LARC) Sales (K Units) by Application (2025-2030)
Table 62. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2019-2024)
Table 63. Global Long-Acting Reversible Contraception(LARC) Sales Market Share by Application (2025-2030)
Table 64. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Long-Acting Reversible Contraception(LARC) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2019-2024)
Table 67. Global Long-Acting Reversible Contraception(LARC) Revenue Market Share by Application (2025-2030)
Table 68. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Long-Acting Reversible Contraception(LARC) Product
Table 74. Bayer Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Long-Acting Reversible Contraception(LARC) Product
Table 79. Merck Recent Developments/Updates
Table 80. Teva Pharmaceutical Corporation Information
Table 81. Teva Pharmaceutical Description and Business Overview
Table 82. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva Pharmaceutical Long-Acting Reversible Contraception(LARC) Product
Table 84. Teva Pharmaceutical Recent Developments/Updates
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Allergan Long-Acting Reversible Contraception(LARC) Product
Table 89. Allergan Recent Developments/Updates
Table 90. HRA Pharma Corporation Information
Table 91. HRA Pharma Description and Business Overview
Table 92. HRA Pharma Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. HRA Pharma Long-Acting Reversible Contraception(LARC) Product
Table 94. HRA Pharma Recent Developments/Updates
Table 95. Eurogine Corporation Information
Table 96. Eurogine Description and Business Overview
Table 97. Eurogine Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Eurogine Long-Acting Reversible Contraception(LARC) Product
Table 99. Eurogine Recent Developments/Updates
Table 100. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Corporation Information
Table 101. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Description and Business Overview
Table 102. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
Table 104. Yantai Family Planning Pharmaceutical Equipment Co., Ltd. Recent Developments/Updates
Table 105. Wuxi Tianyi Medical Equipment Co., Ltd. Corporation Information
Table 106. Wuxi Tianyi Medical Equipment Co., Ltd. Description and Business Overview
Table 107. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Wuxi Tianyi Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
Table 109. Wuxi Tianyi Medical Equipment Co., Ltd. Recent Developments/Updates
Table 110. SMB Corporation Corporation Information
Table 111. SMB Corporation Description and Business Overview
Table 112. SMB Corporation Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. SMB Corporation Long-Acting Reversible Contraception(LARC) Product
Table 114. SMB Corporation Recent Developments/Updates
Table 115. Shenyang Liren Corporation Information
Table 116. Shenyang Liren Description and Business Overview
Table 117. Shenyang Liren Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Shenyang Liren Long-Acting Reversible Contraception(LARC) Product
Table 119. Shenyang Liren Recent Developments/Updates
Table 120. Tianjin Hejie Medical Equipment Co., Ltd. Corporation Information
Table 121. Tianjin Hejie Medical Equipment Co., Ltd. Description and Business Overview
Table 122. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Tianjin Hejie Medical Equipment Co., Ltd. Long-Acting Reversible Contraception(LARC) Product
Table 124. Tianjin Hejie Medical Equipment Co., Ltd. Recent Developments/Updates
Table 125. Cooper Companies Corporation Information
Table 126. Cooper Companies Description and Business Overview
Table 127. Cooper Companies Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Cooper Companies Long-Acting Reversible Contraception(LARC) Product
Table 129. Cooper Companies Recent Developments/Updates
Table 130. AbbVie Allergan Corporation Information
Table 131. AbbVie Allergan Description and Business Overview
Table 132. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. AbbVie Allergan Long-Acting Reversible Contraception(LARC) Product
Table 134. AbbVie Allergan Recent Developments/Updates
Table 135. Organon Corporation Information
Table 136. Organon Description and Business Overview
Table 137. Organon Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Organon Long-Acting Reversible Contraception(LARC) Product
Table 139. Organon Recent Developments/Updates
Table 140. Shanghai Dahua Pharmaceutical Corporation Information
Table 141. Shanghai Dahua Pharmaceutical Description and Business Overview
Table 142. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Shanghai Dahua Pharmaceutical Long-Acting Reversible Contraception(LARC) Product
Table 144. Shanghai Dahua Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Long-Acting Reversible Contraception(LARC) Distributors List
Table 148. Long-Acting Reversible Contraception(LARC) Customers List
Table 149. Long-Acting Reversible Contraception(LARC) Market Trends
Table 150. Long-Acting Reversible Contraception(LARC) Market Drivers
Table 151. Long-Acting Reversible Contraception(LARC) Market Challenges
Table 152. Long-Acting Reversible Contraception(LARC) Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Long-Acting Reversible Contraception(LARC)
Figure 2. Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Long-Acting Reversible Contraception(LARC) Market Share by Type in 2023 & 2030
Figure 4. Intrauterine Devices (IUCs) Product Picture
Figure 5. Subcutaneous Implant Product Picture
Figure 6. Global Long-Acting Reversible Contraception(LARC) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Long-Acting Reversible Contraception(LARC) Market Share by Application in 2023 & 2030
Figure 8. Age 20~24 Years Old
Figure 9. Age 25-34 Years Old
Figure 10. Age 35~44 Years Old
Figure 11. Other
Figure 12. Global Long-Acting Reversible Contraception(LARC) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Long-Acting Reversible Contraception(LARC) Market Size (2019-2030) & (US$ Million)
Figure 14. Global Long-Acting Reversible Contraception(LARC) Sales (2019-2030) & (K Units)
Figure 15. Global Long-Acting Reversible Contraception(LARC) Average Price (US$/Unit) & (2019-2030)
Figure 16. Long-Acting Reversible Contraception(LARC) Report Years Considered
Figure 17. Long-Acting Reversible Contraception(LARC) Sales Share by Manufacturers in 2023
Figure 18. Global Long-Acting Reversible Contraception(LARC) Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Long-Acting Reversible Contraception(LARC) Players: Market Share by Revenue in 2023
Figure 20. Long-Acting Reversible Contraception(LARC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Long-Acting Reversible Contraception(LARC) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2019-2030)
Figure 23. North America Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2019-2030)
Figure 24. United States Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2019-2030)
Figure 27. Europe Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2019-2030)
Figure 28. Germany Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Long-Acting Reversible Contraception(LARC) Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Long-Acting Reversible Contraception(LARC) Revenue Market Share by Region (2019-2030)
Figure 35. China Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2019-2030)
Figure 43. Latin America Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Long-Acting Reversible Contraception(LARC) Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Long-Acting Reversible Contraception(LARC) Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Long-Acting Reversible Contraception(LARC) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Long-Acting Reversible Contraception(LARC) by Type (2019-2030)
Figure 53. Global Revenue Market Share of Long-Acting Reversible Contraception(LARC) by Type (2019-2030)
Figure 54. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Long-Acting Reversible Contraception(LARC) by Application (2019-2030)
Figure 56. Global Revenue Market Share of Long-Acting Reversible Contraception(LARC) by Application (2019-2030)
Figure 57. Global Long-Acting Reversible Contraception(LARC) Price (US$/Unit) by Application (2019-2030)
Figure 58. Long-Acting Reversible Contraception(LARC) Value Chain
Figure 59. Long-Acting Reversible Contraception(LARC) Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed